Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release.
Liu W, Fan T, Li M, Zhang G, Guo W, Yang X, Jiang C, Li X, Xu X, Tang A, Liu K, Liu L, Kong L, Xu Q, Sun Y.
Liu W, et al. Among authors: liu k, liu l.
Int Immunopharmacol. 2020 Apr;81:106206. doi: 10.1016/j.intimp.2020.106206. Epub 2020 Feb 1.
Int Immunopharmacol. 2020.
PMID: 32018066